Canlyniadau Chwilio - Korjian, Serge

Pheochromocytoma Presenting as Partial HELLP Syndrome gan Daaboul, Yazan, Korjian, Serge, Khalil, Lamis, Nemr, Rita

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Medical education in a foreign language and history-taking in the native language in Lebanon – a nationwide survey gan Abi Raad, Vanda, Raad, Kareem, Daaboul, Yazan, Korjian, Serge, Asmar, Nadia, Jammal, Mouin, Aoun Bahous, Sola

Cael y testun llawn Cael y testun llawn Cael y testun llawn

TRENDS IN ACUTE CARDIOVASCULAR DISEASE ADMISSIONS BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC SURGE IN BOSTON gan Diamond, Jamie Elizabeth, McIlvaine, Susan, Korjian, Serge, Cruden, Patrick, Dechen, Tenzin, Piatkowski, Gail, Gavin, Michael

Cael y testun llawn Cael y testun llawn

Patterns of Recovery in Cardiovascular Care after the COVID-19 Pandemic Surge gan Diamond, Jamie E., McIlvaine, Susan, Korjian, Serge, Cruden, Patrick, Dechen, Tenzin, Piatkowski, Gail, Kazi, Dhruv S., Gavin, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity gan Kingwell, Bronwyn A., Nicholls, Stephen J., Velkoska, Elena, Didichenko, Svetlana A., Duffy, Danielle, Korjian, Serge, Gibson, C. Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS... gan Gibson, William J., Gibson, C. Michael, Yee, Megan K., Korjian, Serge, Daaboul, Yazan, Plotnikov, Alexei N., Burton, Paul, Braunwald, Eugene

Cael y testun llawn Cael y testun llawn

The Impact of the COVID-19 Pandemic on Cardiovascular Fellows-in-Training: A National Survey gan Rao, Prashant, Diamond, Jamie, Korjian, Serge, Martin, Lila, Varghese, Merilyn, Serfas, John D., Lee, Ran, Fraiche, Ariane, Kannam, Joseph, Reza, Nosheen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead gan Fabris, Enrico, Korjian, Serge, Coller, Barry S., Ten Berg, Jurrien M., Granger, Christopher B., Gibson, C. Michael, van ’t Hof, Arnoud W. J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary interv... gan Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Goette, Andreas, Lopes, Renato D, Oldgren, Jonas, Korjian, Serge, Windecker, Stephan, Esposito, Giovanni, Vranckx, Pascal, Valgimigli, Marco

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Change in Pulse Wave Velocity and Short‐Term Development of Cardiovascular Events in the Hemodialysis Population gan Korjian, Serge, Daaboul, Yazan, El‐Ghoul, Balsam, Samad, Salam, Salameh, Pascale, Dahdah, Georges, Hariri, Essa, Mansour, Anthony, Spielman, Kathryn, Blacher, Jacques, Safar, Michel E., Bahous, Sola Aoun

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Etiology of End-Stage Renal Disease and Arterial Stiffness among Hemodialysis Patients gan El Ghoul, Balsam, Daaboul, Yazan, Korjian, Serge, El Alam, Andrew, Mansour, Anthony, Hariri, Essa, Samad, Salam, Salameh, Pascale, Dahdah, Georges, Blacher, Jacques, Safar, Michel E., Aoun Bahous, Sola

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial gan Yee, Megan K., Gibson, C. Michael, Nafee, Tarek, Kerneis, Mathieu, Daaboul, Yazan, Korjian, Serge, Chi, Gerald, AlKhalfan, Fahad, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Goldhaber, Samuel Z.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis gan Lee, Jane J., Chi, Gerald, Fitzgerald, Clara, Kazmi, Syed Hassan A., Kalayci, Arzu, Korjian, Serge, Duffy, Danielle, Shaunik, Alka, Kingwell, Bronwyn, Yeh, Robert W., Bhatt, Deepak L., Gibson, C. Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy gan Gibson, C. Michael, Korjian, Serge, Chi, Gerald, Daaboul, Yazan, Jain, Purva, Arbetter, Douglas, Goldhaber, Samuel Z., Hull, Russel, Hernandez, Adrian F., Lopes, Renato D., Gold, Alex, Cohen, Alexander T., Harrington, Robert A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification gan Gibson, C. Michael, Spyropoulos, Alex C., Cohen, Alexander T., Hull, Russell D., Goldhaber, Samuel Z., Yusen, Roger D., Hernandez, Adrian F., Korjian, Serge, Daaboul, Yazan, Gold, Alex, Harrington, Robert A., Chi, Gerald

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design gan Chi, Gerald, Lee, Jane J., Kazmi, Syed H. A., Fitzgerald, Clara, Memar Montazerin, Sahar, Kalayci, Arzu, Korjian, Serge, Heise, Mark, Deckelbaum, Lawrence I., Libby, Peter, Bhatt, Deepak L., Gibson, C. Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future gan Kalayci, Arzu, Gibson, C. Michael, Ridker, Paul M., Wright, Samuel D., Kingwell, Bronwyn A., Korjian, Serge, Chi, Gerald, Lee, Jane J., Tricoci, Pierluigi, Kazmi, S. Hassan, Fitzgerald, Clara, Shaunik, Alka, Berman, Gail, Duffy, Danielle, Libby, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial gan Gibson, C. Michael, Jennings, Lisa K., Chi, Gerald, Yee, Megan K., Halaby, Rim, Nafee, Tarek, AlKhalfan, Fahad, Kerneis, Mathieu, Korjian, Serge, Daaboul, Yazan, Goldhaber, Samuel Z., Hull, Russel D., Hernandez, Adrian F., Cohen, Alexander T., Harrington, Robert A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

d-Dimer elevation and adverse outcomes gan Halaby, Rim, Popma, Christopher J., Cohen, Ander, Chi, Gerald, Zacarkim, Marcelo Rodrigues, Romero, Gonzalo, Goldhaber, Samuel Z., Hull, Russell, Hernandez, Adrian, Mentz, Robert, Harrington, Robert, Lip, Gregory, Peacock, Frank, Welker, James, Martin-Loeches, Ignacio, Daaboul, Yazan, Korjian, Serge, Gibson, C. Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Isc... gan Michael Gibson, C., Korjian, Serge, Tricoci, Pierluigi, Daaboul, Yazan, Yee, Megan, Jain, Purva, Alexander, John H., Steg, P. Gabriel, Lincoff, A. Michael, Kastelein, John J.P., Mehran, Roxana, D’Andrea, Denise M., Deckelbaum, Lawrence I., Merkely, Bela, Zarebinski, Maciej, Ophuis, Ton Oude, Harrington, Robert A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn